Table 3.
Treatment of plantar venous thrombosis.
| Treatment | Total N = 16 | 
|---|---|
| Intermediate-dosed anticoagulation, n (% of total with available data) | 1 (7) | 
| Therapeutic-dosed anticoagulation, n (%) | 14 (93) | 
| Oral anticoagulation | 12 (80) | 
| Vitamin K antagonist, n (%) | 1 (7) | 
| Rivaroxaban, n (%) | 7 (47) | 
| Apixaban, n (%) | 2 (13) | 
| Edoxaban, n (%) | 1 (7) | 
| Parenteral anticoagulation | 3 (20) | 
| Low-molecular-weight heparin, n (%) | 3 (20) | 
| Length of anticoagulation (d), median (IQR) | 90 (90-90) | 
| Nonsteroidal anti-inflammatory drug, n (%) | 0 (0) | 
| Compression therapy, n (%) | 7 (44) |